Can gliotoxin disrupt cellular redox balance and mitochondrial function?

Gliotoxin is an epidithiodioxopiperazine mycotoxin whose reactive disulfide chemistry can perturb intracellular redox homeostasis. The claim is supported primarily by mechanistic, cell-based, and isolated-mitochondria studies rather than human systemic evidence.

Redox and thiol effects

• Gliotoxin reacts directly with glutathione and protein cysteines, forming mixed disulfides and oxidizing thioredoxin and other thiol-dependent targets.
• These reactions shift the intracellular glutathione pool from reduced glutathione (GSH) toward glutathione disulfide (GSSG), reducing cellular antioxidant/reducing capacity.
• GSH is not necessarily protective: it can reduce gliotoxin to dithiol-gliotoxin, supporting intracellular retention and subsequent redox cycling.

ROS-generating mechanism

• Dithiol-gliotoxin can be reoxidized by molecular oxygen, generating superoxide and downstream reactive oxygen species (ROS).
• This provides a coherent link between thiol reactivity, depletion/oxidation of cellular reducing systems, and oxidative stress. ROS output varies with cell type, exposure concentration, timing, formulation, and intracellular thiol status.

Mitochondrial and cell-death consequences

• In preclinical models, gliotoxin is associated with loss of mitochondrial membrane potential, cytochrome-c release, caspase-dependent apoptosis, and reduced ATP.
• Mitochondrial effects increased across 10–90 μM exposures in HeLa and SW1353 cells. In neuronal SH-SY5Y cells, ATP declined significantly at concentrations above 0.25 μM.
• Thiol-dependent mitochondrial permeability-related effects are supported, but unchanged oxygen consumption in one system means these findings should not be interpreted as definitive evidence of primary respiratory-chain inhibition.

Bottom line

• Gliotoxin can disrupt cellular redox balance through thiol modification and oxygen-dependent redox cycling, with context-dependent ROS generation and preclinical mitochondrial injury. The relative importance of direct mitochondrial effects versus secondary oxidative and apoptotic injury remains unresolved, and these mechanisms do not by themselves establish systemic effects in humans.